Delivery Order SPE2DB20D3303-SPE2DB25FA3BW
- Not listed
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $36,653.26 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods to be delivered to Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 14, 2025, with completion targeted for August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $3,959.27 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 26, 2025, and represents a non-set-aside procurement. The products will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.48 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed price pricing and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical supply...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $25,148.64 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods, with an ultimate completion date of July 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for...
- The Defense Logistics Agency awarded a $1,784.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7 Gen 5 insulin infusion pods. The contract, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitive award with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.30 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 4, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply chain requirements. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3BWDelivery Order
The Defense Logistics Agency awarded a $11,008.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical devices across multiple therapeutic domains, including diabetes management supplies, specialty medications, vaccines, and other medical commodities. This delivery order for OmniPod 5 insulin pods reflects the contractor's ongoing role in supporting the Defense Health Agency and other government healthcare systems with essential medical supplies necessary for soldier and beneficiary care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 8/28/25 |